Multiplex Assay Kit for Creatine Kinase, Muscle (CKM) ,etc. by FLIA (Flow Luminescence Immunoassay)

CK-MM; CKMM; CK3; CK-M; MM-CK; M-CK; Creatine kinase M-type, N-terminally processed

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Creatine Kinase, Muscle (CKM) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Creatine Kinase, Muscle (CKM) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Creatine Kinase, Muscle (CKM) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Creatine Kinase, Muscle (CKM) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 92-104 96
EDTA plasma(n=5) 78-91 81
heparin plasma(n=5) 98-105 102
sodium citrate plasma(n=5) 78-93 82

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Creatine Kinase, Muscle (CKM) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Creatine Kinase, Muscle (CKM) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Creatine Kinase, Muscle (CKM) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 91-99% 99-105% 79-94% 94-105%
EDTA plasma(n=5) 93-101% 80-89% 87-101% 96-104%
heparin plasma(n=5) 95-104% 78-89% 85-99% 92-101%
sodium citrate plasma(n=5) 83-101% 82-102% 84-93% 97-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:CKM) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Journal of Inflammation Assessment of endothelium and inflammatory response at the onset of reperfusion injury in hand surgery PubMed: 22583529
PLoS One Extraocular Muscle Characteristics Related to Myasthenia Gravis Susceptibility PubMed: PMC3568149
Kidney Int. Fructokinase activity mediates dehydration-induced renal injury Pubmed: 24336030
Methylxanthines and cardiotoxicity Methylxanthine induced cardiotoxicity and its mechanisms: An experimental study 230b:34bf146150b42971d76dda5e8329bc5f2f0b.pdf
Molecular Medicine Reports Protective effects of N (2)‑L‑alanyl‑L‑glutamine mediated by the JAK2/STAT3 signaling pathway on myocardial ischemia reperfusion Pubmed:29393473
Toxicological Sciences Proteomic and Metabolomic Profiling Identify Plasma Biomarkers for Exposure to Ultra-low Levels of Carfentanil Pubmed: 30321427
Clinical & Translational Oncology The effects of human sera conditioned by high-intensity exercise sessions and training on the tumorigenic potential of cancer cells Pubmed: 32447643
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
NPA109Ra01 Native Creatine Kinase, Muscle (CKM) Positive Control; Immunogen; SDS-PAGE; WB.
RPA109Ra01 Recombinant Creatine Kinase, Muscle (CKM) Positive Control; Immunogen; SDS-PAGE; WB.
PAA109Ra02 Polyclonal Antibody to Creatine Kinase, Muscle (CKM) WB; IHC; ICC; IP.
PAA109Ra01 Polyclonal Antibody to Creatine Kinase, Muscle (CKM) WB; IHC; ICC; IP.
LAA109Ra71 Biotin-Linked Polyclonal Antibody to Creatine Kinase, Muscle (CKM) WB; IHC; ICC.
MAA109Ra21 Monoclonal Antibody to Creatine Kinase, Muscle (CKM) WB; IHC; ICC; IP.
LAA109Ra72 Biotin-Linked Monoclonal Antibody to Creatine Kinase, Muscle (CKM) WB; IHC; ICC.
SEA109Ra ELISA Kit for Creatine Kinase, Muscle (CKM) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA109Ra CLIA Kit for Creatine Kinase, Muscle (CKM) Chemiluminescent immunoassay for Antigen Detection.
LMA109Ra Multiplex Assay Kit for Creatine Kinase, Muscle (CKM) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
PSA109Ra01 Antibody Pair for Creatine Kinase, Muscle (CKM) ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays.
KSA109Ra01 ELISA Kit DIY Materials for Creatine Kinase, Muscle (CKM) Main materials for "Do It(ELISA Kit) Yourself"